Unix Pharmaceuticals is a rapidly growing pharmaceutical company founded by a team of scientists and specialists in chemistry, biotechnology, and industrial manufacturing. Since its establishment, the company has focused on the development and production of high-quality pharmaceutical products that meet modern international standards.
The manufacturing base of Unix Pharmaceuticals is located in China—one of the key centers of the global pharmaceutical industry. This allows the company to effectively combine advanced technologies, scalable production, and cost-efficient operations. All processes are organized in accordance with strict quality and safety requirements, including compliance with GMP standards.
The company’s core activities include the development and production of generic medicines as well as active pharmaceutical ingredients (APIs). Unix Pharmaceuticals places strong emphasis on improving synthesis technologies, formula stability, and the bioavailability of its final products.
The company actively invests in research and laboratory development, striving to implement innovative solutions and enhance product effectiveness. A key part of its strategy is collaboration with international partners, scientific institutions, and distributors.
The mission of Unix Pharmaceuticals is to increase access to high-quality pharmaceutical solutions and support the development of the global healthcare system. The company is committed to ensuring reliability, transparency, and sustainable growth across all aspects of its operations.
